New Options in Schizophrenia Management

Share

Program Content

Activities

  • New Options in Schizophrenia Management: Overview and Current Guidelines
    New Options in Schizophrenia Management: Overview and Current Guidelines
    Medical Minute
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

  • New Options in Schizophrenia Management: Addressing Adherence
    New Options in Schizophrenia Management: Addressing Adherence
    Medical Minute
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

  • New Options for Schizophrenia Management: Current and Emerging Treatment Options
    New Options for Schizophrenia Management: Current and Emerging Treatment Options
    Medical Minute
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

  • Pharmacotherapies for Schizophrenia
    Pharmacotherapies for Schizophrenia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

  • Schizophrenia Addressing Adherence
    New Options in Schizophrenia Management: Addressing Adherence
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

  • Schizophrenia Current and Emerging
    New Options for Schizophrenia Management: Current and Emerging Treatment Options
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

  • Schizophrenia Management
    New Options in Schizophrenia Management: Overview and Current Guidelines
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 07, 2022

    Expires: July 06, 2023

Provided by

ProCE Banner

Supporters

Alkermes, Inc.

Teva Pharmaceuticals